Highlights: Q1
- Like-for-like net revenue growth excluding RBP of 4%, well ahead of our market growth
- Strong growth in emerging market areas
- Satisfactory performance in ENA in challenging market conditions
- Growth driven by Dettol / Lysol, Harpic, Finish, and Durex
- RBP - volume (mg) market share of Film grown to 53%
Commenting on these results, Rakesh Kapoor, Chief Executive Officer, said:
"Reckitt Benckiser's first quarter results were on track and in line with our ingoing expectations. High quality, volume led LFL growth of 4% was driven by c ontinued excellent performance in Emerging Market Areas and the success of innovations like Veet Easy Wax Roll-On and the Lysol No-Touch Kitchen System.
RBP continues to make very good progress with the patient preferred Suboxone sublingual film now at 53% market volume share, up from 48% at the end of 2011.
These results give us the confidence to reiterate our FY 2012 target of like-for-like net revenue growth* of 200bp above our market growth rate of 1-2%. We also expect to maintain full year operating margins.*"
